Sanofi Pulls Obesity Drug Acomplia From EU Market
French drugmaker Sanofi-Aventis has agreed to stop selling the anti-obesity drug Acomplia after European authorities called for sales of the drug to be suspended....To view the full article, register now.
Already a subscriber? Click here to view full article